Biography
Dr. Gellad's research
focuses on physician prescribing practices and on policy issues affecting
access and adherence to medications for patients, optimizing the quality,
safety, and value of prescribing and prescription drug use. He is a nationally
recognized authority on improving the measurement of medication adherence, has
authored more than 100 articles in leading medical and policy journals, and he
is a regular commentator on pharmaceutical policy issues in major news outlets
including the New York Times, Washington Post, and NPR, and the Wall Street
Journal.
He was the recipient of a
career development award from the Department of Veterans Affairs to study the
quality and efficiency of prescribing in the VA and continues to lead research
funded by the VA, NIH, CDC, and the state of Pennsylvania on multiple studies
of pharmaceutical policy and prescription use. His work spans clinical areas,
from diabetes, to Hepatitis C, to prescription drug and substance abuse. His
policy area of expertise is prescription drug pricing and spending. He is a
former member of the Food and Drug Administration (FDA) advisory committee on
nonprescription drugs and currently an alternate member of the FDA Drug Safety
Oversight Board.
Dr. Gellad is board
certified in internal medicine and completed a residency and chief residency in
internal medicine at Brigham and Women's Hospital and Harvard Medical School.
He sees primary care patients in the VA Pittsburgh Heathcare System and attends
on the inpatient general medical service.